
Home » FDA APPROVES CUBICIN FOR MORE USES
FDA APPROVES CUBICIN FOR MORE USES
May 26, 2006
The FDA has approved a much broader use for Cubist Pharmaceuticals's Cubicin intravenous antibiotic.
The approval involves expanding Cubicin's indication from skin infections to also treat bloodstream infections, including a form of endocarditis. Cubist said it will begin marketing immediately.
KEYWORDS Drug Pipeline Alert
Upcoming Events
-
10Mar
-
16Mar
-
18Mar
-
23Mar
-
30Mar
-
06Apr